Gene score IDs prognosis in metastatic neuroblastoma

August 29, 2012
Gene score IDs prognosis in metastatic neuroblastoma
For children with metastatic MYCN-nonamplified neuroblastoma diagnosed at age 18 months or older, increased expression of tumor-associated inflammatory genes seems to correlate with poor prognosis, according to a study published online Aug. 27 in the Journal of Clinical Oncology.

(HealthDay)—For children with metastatic MYCN-nonamplified neuroblastoma (NBL-NA) diagnosed at age 18 months or older, increased expression of tumor-associated inflammatory genes seems to correlate with poor prognosis, according to a study published online Aug. 27 in the Journal of Clinical Oncology.

Shahab Asgharzadeh, M.D., of Children's Hospital of Los Angeles, and colleagues examined whether genes related to tumor-associated correlate with differences in survival by age at diagnosis. Immunohistochemical studies were conducted on tumor-associated macrophages (TAMs) from 71 localized and metastatic neuroblastomas. The prediction of progression-free survival was examined based on expression of 44 tumor and inflammatory genes which were evaluated in 133 metastatic NBL-NAs. The results were validated in tumors from 91 high- enrolled in two additional studies.

The researchers observed an increase in infiltration of TAMs in metastatic neuroblastomas versus locoregional tumors. Patients aged 18 months or older at diagnosis had increased expression of inflammation-related genes compared with those diagnosed at a younger age. Twenty-five percent of the accuracy of a novel 14-gene tumor classification score was due to expression of five genes representing TAMs. For children diagnosed with NBL-NA at 18 months or older, the progression-free survival at five years was significantly higher for those with a low- versus high-, in each of the three independent clinical trials.

"Our study reports the first evidence of a role for intratumor inflammation in metastatic neuroblastomas and provides a validated prognostic signature for children with metastatic NBL-NA," the authors write.

The study was supported in part by a grant from Amgen.

Explore further: High survival with surgery in low-risk neuroblastoma

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

High survival with surgery in low-risk neuroblastoma

April 25, 2012
(HealthDay) -- Surgery alone results in high five-year event-free and overall survival (EFS and OS) rates for patients with low-risk stage 2a and 2b neuroblastoma (NBL), according to research published online April 23 in ...

Study finds association between genetic mutation and age at diagnosis for common childhood cancer

March 13, 2012
Certain mutations of the gene ATRX were associated with age at diagnosis in children and young adults with advanced-stage neuroblastoma, a cancer that grows in parts of the nervous system, according to a study in the March ...

Circulating tumor cells not linked to survival in newly diagnosed inflammatory breast cancer

December 9, 2011
The presence of circulating tumor cells in the blood appears to have no relationship to survival in women who have just been diagnosed with inflammatory breast cancer, according to new research from Fox Chase Cancer Center. ...

Researchers validate staging classifications for neuroendocrine pancreatic tumor surgery response

April 3, 2012
Researchers at Moffitt Cancer Center have carried out a study to validate the utility of new tumor classification systems for staging and predicting relapse-free survival for patients with neuroendocrine tumors (NETs) and ...

Recommended for you

Researchers release first draft of a genome-wide cancer 'dependency map'

July 27, 2017
In one of the largest efforts to build a comprehensive catalog of genetic vulnerabilities in cancer, researchers from the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute have identified more than 760 genes ...

Cancer-death button gets jammed by gut bacterium

July 27, 2017
Researchers at Michigan Medicine and in China showed that a type of bacterium is associated with the recurrence of colorectal cancer and poor outcomes. They found that Fusobacterium nucleatum in the gut can stop chemotherapy ...

Long-sought mechanism of metastasis is discovered in pancreatic cancer

July 27, 2017
Cells, just like people, have memories. They retain molecular markers that at the beginning of their existence helped guide their development. Cells that become cancerous may be making use of these early memories to power ...

Blocking the back-door that cancer cells use to escape death by radiotherapy

July 27, 2017
A natural healing mechanism of the body may be reducing the efficiency of radiotherapy in breast cancer patients, according to a new study.

Manmade peptides reduce breast cancer's spread

July 27, 2017
Manmade peptides that directly disrupt the inner workings of a gene known to support cancer's spread significantly reduce metastasis in a mouse model of breast cancer, scientists say.

Glowing tumor technology helps surgeons remove hidden cancer cells

July 27, 2017
Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) - through the use of a contrast agent that makes tumor cells ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.